Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

California Launches Initiative to Advance Precision Medicine

April 17, 2015 10:35 am | by UCSF | News | Comments

Gov. Jerry Brown is launching a statewide initiative with the University of California, to advance the field of precision medicine. The effort will involve collaborating with other academic and industry partners and starting to build the infrastructure and assemble the resources necessary to further develop the field. Read more...

TOPICS:

The Placebome?

April 17, 2015 10:29 am | by Harvard Medical School | News | Comments

How genomics might influence the role of the placebo in patient care and clinical research...

TOPICS:

Impact of Label-Free Cell-Based Assays and the Holistic Calorimetry Approach

April 17, 2015 10:23 am | by Magnus Jansson, Ph.D., CSO, SymCel Sverige AB | Articles | Comments

New, innovative technology solves challenges in antibiotic resistance and the drug development cycle. Read more...

TOPICS:
Advertisement

Electronic Micropump Could Deliver Treatment to Specific Brain Region

April 17, 2015 10:13 am | by Stephanie Guzowski, Editor | News | Comments

There is an exactness that must be taken into account when treating neurological disorders. In treating epilepsy, for example, a condition in which nerve cell activity in the brain is disturbed, causing seizures, a drug needs to be delivered directly to a specific brain region—but without negatively affecting healthy brain regions. Read more...

TOPICS:

Synthetic Drugs: Evidence That They Can Cause Cancer

April 17, 2015 8:19 am | by Medical University of Vienna | News | Comments

Synthetic cannabinoids are difficult to identify chemically and the possible unwanted toxic effects that can occur following their consumption have so far barely been investigated. Read more...

TOPICS:

Actelion Advances Clinical Development of its Specialty Immunology Pipeline Compounds

April 17, 2015 8:12 am | News | Comments

Actelion announced that it is accelerating its clinical development efforts in the field of immunological disorders. Read more...

TOPICS:

Gene Variant Linked to Cancer

April 17, 2015 8:11 am | by Washington University in St. Louis | News | Comments

Smokers with a specific genetic variation are more likely to keep smoking longer than those who don’t have the gene variant. Read more...

TOPICS:
Advertisement

Scientists Discover Protein That Boosts Immunity to Viruses and Cancer

April 17, 2015 8:10 am | by Imperial College London | News | Comments

Scientists have discovered a protein that plays a central role in promoting immunity to viruses and cancer, opening the door to new therapies. Read more...

TOPICS:

Evidence Grows that Melanoma Drugs Benefit Some Lung Cancer Patients

April 17, 2015 8:09 am | by European Society for Medical Oncology | News | Comments

A subset of lung cancer patients can derive important clinical benefits from drugs that are more commonly used to treat melanoma. Read more...

TOPICS:

Pfizer Breast Cancer Drug Shows Promising Results

April 16, 2015 2:19 pm | by Stephanie Guzowski, Editor | News | Comments

Pfizer said on Wednesday a late-stage trial of its treatment for advanced breast cancer, Ibrance, was stopped early after it met its primary goal of delaying disease progression. Read more...

TOPICS:

Identifying Molecular Mechanism That Makes Malaria Parasites Drug-Resistant

April 16, 2015 12:57 pm | by University of Notre Dame | News | Comments

University of Notre Dame researchers led an international team to identify a molecular mechanism responsible for making malaria parasites resistant to artemisinins, the leading class of antimalarial drugs. Read more...

TOPICS:

How PBPK Models Advance the Understanding of Therapeutic Antibodies

April 16, 2015 10:40 am | by Suzanne K. Minton, Ph.D., Scientific Content Specialist, Certara | Articles | Comments

Monoclonal antibodies (mAbs) are large Y-shaped proteins that are produced by immune cells to defend the body against pathogens. A hallmark of antibodies is their ability to specifically bind to epitopes, or the parts of the antigen that the immune system recognizes, on their molecular targets, which has been harnessed by drug companies to develop treatments for certain cancers and autoimmune diseases. Read more...

TOPICS:

Abbot Receives FDA Clearance for New Blood Glucose Meter

April 16, 2015 10:38 am | News | Comments

The cost of insurance premiums and employee medical claims continues to rise in the United States, which is especially challenging for people living with chronic conditions such as diabetes. Read more...

TOPICS:

Abbvie's Chronic Hepatitis C Treatment Granted Priority Review in Japan

April 16, 2015 10:31 am | News | Comments

AbbVie today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has granted priority review for its investigational, two direct-acting antiviral treatment of ombitasvir/paritaprevir/ritonavir. Read more...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading